[Translation] A randomized, double-blind, double-dummy, parallel-controlled, multicenter phase II clinical trial of the efficacy and safety of Tongshuan Jiuxin tablets in the treatment of coronary heart disease angina pectoris
对通栓救心片治疗冠心病心绞痛(气滞血瘀证)的临床用药剂量进行初步探索,为Ⅲ期临床试验用药提供依据,对临床有效性进行初步探索及评价,对临床安全性进行评价。
[Translation] The clinical dosage of Tongshuan Jiuxin Tablets in the treatment of coronary heart disease angina pectoris (Qi stagnation and blood stasis syndrome) was preliminarily explored to provide the basis for phase III clinical trials, preliminary exploration and evaluation of clinical efficacy, and evaluation of clinical safety.